Unravelling the Link between Inflammatory Biomarkers and Coronary Artery Ectasia Severity: A Systematic Review and

Hang Zhang1, Xin Chen2

  • 1Department of Cardiology, Tianjin First Central Hospital, Tianjin, China.

Cardiology
|June 12, 2026
PubMed

Insights

Inflammation markers like high-sensitivity C-reactive protein (hs-CRP), Interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) are linked to coronary artery ectasia (CAE). Elevated hs-CRP and lymphocyte levels correlate with CAE severity.

Area of Science:

  • Cardiology
  • Immunology
  • Biomarkers

Background:

  • Coronary artery ectasia (CAE) is increasingly detected, yet its association with inflammation is debated.
  • Understanding the inflammatory basis of CAE is crucial for diagnosis and management.

Purpose of the Study:

  • To investigate the correlation between various inflammatory markers and the occurrence and severity of CAE.
  • To identify specific inflammatory indicators associated with CAE development and progression.

Main Methods:

  • A comprehensive meta-analysis of studies from PubMed, Embase, Cochrane Library, and Web of Science.
  • Inclusion of 53 studies with 9,168 participants, analyzing inflammatory markers like hs-CRP, IL-6, TNF-α, WBC, and lymphocyte counts.
  • Statistical analysis using Review Manager 5.3 with fixed-or random-effect models, calculating mean difference (MD) and odds ratio (OR).

Main Results:

  • CAE patients exhibited higher levels of high-sensitivity C-reactive protein (hs-CRP), Interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) compared to controls.
  • Elevated white blood cell (WBC) to neutrophil ratios were observed in CAE patients versus coronary artery disease (CAD) and non-coronary artery (NCA) populations.
  • hs-CRP and lymphocyte levels were positively correlated with CAE severity, with hs-CRP (OR=1.78) and WBC (OR=1.00) identified as significant factors in multivariate analysis.

Conclusions:

  • Inflammatory markers including hs-CRP, IL-6, TNF-α, and specific inflammatory cells are associated with the occurrence of CAE.
  • hs-CRP and lymphocyte levels serve as potential indicators for assessing the severity of CAE.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...